Silo Pharma reported earnings of -$ 0.21 per SILO share on Nov 13, 2026, falling short of analysts' expectations by
| Report Date | Nov 13, 2026 |
|---|---|
| Forecasted EPS | -$ 4.80 |
| Earnings Per Share (Surprise) | -$ 0.21 (+$ 4.59) |
| Last Year's EPS | -$ 1.19 |
| EPS YoY Change |
Out of the last 63 earnings reporting periods, Silo Pharma beat analysts’ expectations 4 times and fell short of expectations 8 time(s). Silo Pharma reported earnings per share of -$ 0.21 in the last report surpassing an estimated EPS of -$ 4.80 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 4.80 | -$ 0.21 | -$ 0.12 | |
| Aug 13, 2026 | -$ 0.32 | -$ 0.76 | -$ 0.19 | |
| May 13, 2026 | -$ 0.32 | -$ 1.80 | -$ 3.45 | |
| Mar 27, 2026 | - | -$ 0.99 | -$ 0.41 | |
| Nov 13, 2025 | -$ 0.20 | -$ 0.12 | -$ 0.22 | |
| Aug 13, 2025 | -$ 0.20 | -$ 0.19 | -$ 0.31 | |
| May 9, 2025 | -$ 0.21 | -$ 3.45 | -$ 0.28 | |
| Mar 28, 2025 | -$ 0.20 | -$ 0.41 | -$ 0.36 | |
| Nov 12, 2024 | -$ 0.21 | -$ 0.22 | -$ 0.21 | |
| Aug 13, 2024 | -$ 0.32 | -$ 0.31 | -$ 4.80 | |
| May 13, 2024 | -$ 0.21 | -$ 0.28 | -$ 4.35 | |
| Mar 25, 2024 | -$ 0.20 | -$ 0.36 | -$ 0.78 | |
| Nov 13, 2023 | -$ 0.20 | -$ 0.21 | -$ 0.51 | |
| Aug 11, 2023 | -$ 4.80 | -$ 4.80 | -$ 0.41 | |
| May 12, 2023 | - | -$ 4.35 | -$ 0.31 | |
| Mar 24, 2023 | - | -$ 0.78 | -$ 0.57 | |
| Nov 10, 2022 | - | -$ 0.51 | $ 3.16 | |
| Aug 1, 2022 | - | -$ 0.41 | -$ 0.24 | |
| May 13, 2022 | - | -$ 0.31 | -$ 0.55 | |
| Mar 28, 2022 | - | -$ 0.57 | -$ 0.60 |
Silo Pharma’s stock was trading at $ 1.91 on Nov 12, 2026 a day before the last earnings report was released.
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 0.21 | $ 1.91 | ||
| Aug 13, 2026 | -$ 0.76 | $ 3.10 | $ 3.20 | |
| May 13, 2026 | -$ 1.80 | $ 5.94 | $ 5.91 | |
| Mar 27, 2026 | -$ 0.99 | $ 5.69 | $ 5.14 | |
| Nov 13, 2025 | -$ 0.12 | $ 6.77 | $ 6.20 | |
| Aug 13, 2025 | -$ 0.19 | $ 10.11 | $ 10.38 | |
| May 9, 2025 | -$ 3.45 | $ 12.22 | $ 16.05 | |
| Mar 28, 2025 | -$ 0.41 | $ 19.80 | $ 17.55 | |
| Nov 12, 2024 | -$ 0.22 | $ 19.80 | $ 16.50 | |
| Aug 13, 2024 | -$ 0.31 | $ 19.50 | $ 20.55 | |
| May 13, 2024 | -$ 0.28 | $ 25.20 | $ 27.15 | |
| Mar 25, 2024 | -$ 0.36 | $ 27.90 | $ 29.10 | |
| Nov 13, 2023 | -$ 0.21 | $ 20.40 | $ 19.50 | |
| Aug 11, 2023 | -$ 4.80 | $ 30.60 | $ 29.85 | |
| May 12, 2023 | -$ 4.35 | $ 32.70 | $ 31.35 | |
| Mar 24, 2023 | -$ 0.78 | $ 30.60 | $ 30.15 | |
| Nov 10, 2022 | -$ 0.51 | $ 51.22 | $ 52.20 | |
| Aug 1, 2022 | -$ 0.41 | $ 103.80 | $ 97.50 | |
| May 13, 2022 | -$ 0.31 | $ 108.90 | $ 108.90 | |
| Mar 28, 2022 | -$ 0.57 | $ 114.15 | $ 142.65 |
Silo Pharma released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Silo Pharma beat analysts’ expectations during the last earnings period by
